Published in Arch Esp Urol on March 01, 1999
Unexplained association between cystitis glandularis and interstitial cystitis in females: a retrospective study. Int Urogynecol J (2015) 0.75
European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol (2004) 2.65
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2012) 2.53
Primary superficial bladder cancer risk groups according to progression, mortality and recurrence. J Urol (2000) 2.38
TNM staging of renal cell carcinoma: Workgroup No. 3. Union International Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer (1997) 1.80
Metastatic tumor of the epididymis and spermatic cord. Eur Urol (1983) 1.50
[Squamous cell carcinoma of the penis: treatment protocol according to our 14 years of experience]. Arch Esp Urol (1997) 1.37
Staging of early prostate cancer: a proposed tumor volume-based prognostic index. Urology (1993) 1.20
EAU Guidelines on Penile Cancer. Eur Urol (2004) 1.19
[EAU guidelines on testicular cancer: 2011 update. European Association of Urology]. Actas Urol Esp (2011) 1.19
Small cell carcinoma of the urinary bladder. Presentation of 23 cases and review of 134 published cases. Eur Urol (2001) 1.11
Grade, local stage and growth pattern as prognostic factors in carcinoma of the penis. Eur Urol (1997) 1.06
Renal hematoma as a complication of extracorporeal shock wave lithotripsy. Scand J Urol Nephrol (1999) 1.03
Morphological identification of the patterns of prostatic intraepithelial neoplasia and their importance. J Clin Pathol (2000) 1.02
Balanitis xerotica obliterans in children. J Urol (1986) 0.92
Growing teratoma syndrome: experience of a single institution. Eur Urol (1997) 0.90
Variation in reporting of cancer extent and benign histology in prostate biopsies among European pathologists. Virchows Arch (2014) 0.87
Testicular pseudolymphoma. Eur Urol (1986) 0.85
Matrix Metalloproteinases and Bladder Cancer: What is New? ISRN Urol (2012) 0.85
Significance of ureteral carcinoma in situ in specimens of cystectomy. Eur Urol (1994) 0.83
Handling and reporting of radical prostatectomy specimens in Europe: a web-based survey by the European Network of Uropathology (ENUP). Histopathology (2008) 0.83
Hepatocarcinoma and oral contraceptives. Lancet (1978) 0.82
Precancerous lesions in the kidney. Scand J Urol Nephrol Suppl (2000) 0.81
Clear cell adenocarcinoma in a female urethral diverticulum. Scand J Urol Nephrol (2000) 0.81
[Transitional cell carcinoma of the bladder: behavior in young adults]. Arch Esp Urol (1996) 0.81
Consensus statement on terminology: recommendation to use atypical adenomatous hyperplasia in place of adenosis of the prostate. Am J Surg Pathol (1994) 0.81
Treatment of transitional cell carcinoma of the ureter: is the controversy justified? Eur Urol (1990) 0.81
Molecular staging of bladder cancer with RT-PCR assay for CK20 in peripheral blood, bone marrow and lymph nodes: comparison with standard histological staging. Anticancer Res (2006) 0.80
What is the added value of combined core biopsy and fine needle aspiration in the diagnostic process of renal tumours? World J Urol (2011) 0.80
Intraepithelial lesions of urinary bladder: morphologic considerations. Scand J Urol Nephrol Suppl (2000) 0.79
Desmoplastic small round-cell tumor. Am J Surg Pathol (1992) 0.79
Altered gene expression signature of early stages of the germ line supports the pre-meiotic origin of human spermatogenic failure. Andrology (2014) 0.79
Transitional cell carcinoma of the prostate. Eur Urol (1985) 0.79
[Bacteriologic assessment of the lower urinary tract and genital area in patients with recurrent urinary tract infections]. Arch Esp Urol (2000) 0.79
Preservation of renal function in a patient with Fabry nephropathy on enzyme replacement therapy. Clin Nephrol (2008) 0.78
[Encrusted cystitis. Is it always alkaline?]. Arch Esp Urol (1999) 0.78
EAU guidelines on testicular cancer. Eur Urol (2001) 0.77
Primary bladder carcinoma in situ: assessment of early BCG response as a prognostic factor. Eur Urol (1998) 0.77
Origin of high-grade superficial bladder cancer. Eur Urol (1987) 0.76
Meconium vaginalitis. Br J Urol (1991) 0.76
Large cell calcifying Sertoli cell tumour of the testis. Histopathology (1995) 0.76
Histological evaluation of superficial bladder tumors treated by Nd-YAG laser and transurethral resection. Eur Urol (1991) 0.76
The role of repeat transurethral resection in stage A1 carcinoma of the prostate. Eur Urol (1989) 0.76
Fibrous polyp of the ureter. Eur Urol (1981) 0.76
Report of the Committee on Staging and Pathology. Cancer (1992) 0.75
Re: Transurethral resection of the prostate versus transurethral electrovaporization of the prostate: a blinded, prospective comparative study with 1-year followup. J Urol (1998) 0.75
Renal tuberculosis and hypertension: value of the renal vein renin ratio. Eur Urol (1984) 0.75
[Isolated bladder carcinoma in situ]. Actas Urol Esp (1987) 0.75
[Role of percutaneous endopyelotomy in the treatment of pyeloureteral junction stenosis after failed ureteropyeloplasty]. Arch Esp Urol (1997) 0.75
[Bladder malacoplakia: 14-year follow-up of a case]. Arch Esp Urol (1999) 0.75
[Internal urinary diversion with a double-J ureteral catheter. 100 consecutive cases]. Arch Esp Urol (1986) 0.75
[Late recurrence of renal carcinoma on the nephrectomy scar]. Actas Urol Esp (1986) 0.75
[Treatment of bladder endometriosis using the Nd-Yag laser]. Arch Esp Urol (1991) 0.75
[Polycystic kidney in the adult and kidney transplantation. Our experience]. Arch Esp Urol (1996) 0.75
Differential diagnosis and evaluation of the clinical course of transurethrally resected T1G3 urothelial carcinoma of the bladder by DNA image cytometry. Anticancer Res (2005) 0.75
[Mucinous adenocarcinoma of the urachus]. Actas Urol Esp (1992) 0.75
Balanitis xerotica obliterans: surgical treatment. Eur Urol (1988) 0.75
[Comparative population-based survey as evaluation method of prostate disease changes]. Actas Urol Esp (1999) 0.75
Autopsy study of liver cell carcinoma in Barcelona, Spain. Pathol Annu (1976) 0.75
[Value of radical cystectomy in the treatment of infiltrating bladder cancer]. Actas Urol Esp (1989) 0.75
[Relevance of the clinical-pathological predictive factors in force in chromophobe renal cell cancer]. Actas Urol Esp (2012) 0.75
Value of in vivo mucosa-staining test with methylene blue in the diagnosis of pretumoral and tumoral lesions of the bladder. Eur Urol (1987) 0.75
Effectiveness and morbidity of secondary retroperitoneal lymph node dissection after chemotherapy in testicular tumors. Eur Urol (1983) 0.75
[Prostatic cysts of the midline: management and follow-up]. Arch Esp Urol (2001) 0.75
Epithelioid sarcoma of penis. Eur Urol (1983) 0.75
Small kidney and hypertension: selection of patients for surgery. Urol Int (1986) 0.75
Intratubular germ cell tumor. Relation with 'burned-out' tumor and testicular germinal neoplasia. Eur Urol (1991) 0.75
[A nephrogenic adenoma during treatment with intravesical BCG]. Arch Esp Urol (1992) 0.75
[Efficacy of oxybutynin chloride in children with vesico-ureteral reflux and detrusor instability]. An Esp Pediatr (1997) 0.75
[Determination of prognostic factors in incidental prostatic carcinoma]. Arch Esp Urol (1993) 0.75
[Hepatocarcinoma. Surgical resection of 2 cases unrelated to hepatic cirrhosis]. Rev Esp Enferm Apar Dig (1978) 0.75
[Lumbar ureteral fistula after aortobifemoral bypass in a patient with ileal conduit and pelvic irradiation]. Actas Urol Esp (1998) 0.75
[BCG and radiotherapy: the compatibility of 2 conservative treatments for cancer of the urinary bladder]. Arch Esp Urol (1999) 0.75
Value of random endoscopic biopsy in the diagnosis of bladder carcinoma in situ. Eur Urol (1987) 0.75
[Isolated renal angiomyolipoma. Study of 10 cases]. J Urol (Paris) (1983) 0.75
Management of small renal masses. Adv Urol (2009) 0.75
[Cytoscopic follow-up of initial G3T1 bladder tumors treated with BCG]. Arch Esp Urol (2001) 0.75
[Laser therapy of superficial tumors of the bladder]. Arch Esp Urol (1990) 0.75
[Nephrotic syndrome associated with ampulloma]. Rev Esp Enferm Apar Dig (1989) 0.75
[Clinical trial of the effect of urethral catheter on the etiology of urethral stenosis following transurethral resection of the prostate]. Arch Esp Urol (1999) 0.75
[Radical nephrectomy following heart transplantation]. Actas Urol Esp (1997) 0.75
[Endoscopic lithotripsy by means of Lithoclast]. Arch Esp Urol (1995) 0.75
[Endoscopic biopsy in the staging of infiltrating tumor of the bladder]. Arch Esp Urol (1994) 0.75
Renal oncocytoma: a true clinical entity? Eur Urol (1987) 0.75
[Urothelial carcinoma in a woman with autosomal dominant polycystic kidney disease: description of a case and review of the literature]. Actas Urol Esp (2008) 0.75
[Drug-induced fever caused by prophylactic isoniazid in bladder instillations with BCG]. Actas Urol Esp (1992) 0.75
[Urethral condyloma in the male: experience with 48 cases]. Arch Esp Urol (1996) 0.75
[Alternatives to transurethral resection of benign hypertrophy of the prostate]. Arch Esp Urol (1991) 0.75
[Endoscopic surgery of bladder diverticulum]. Actas Urol Esp (1996) 0.75
[Pelvic melanoma]. Actas Urol Esp (1992) 0.75
[Prognostic factors and predictive tables of non-localized prostate cancer that exclude therapy by radical prostatectomy]. Actas Urol Esp (1998) 0.75
[Intracranial metastasis in prostatic cancer]. Actas Urol Esp (2000) 0.75
[Chronicle of TRU for BPH]. Arch Esp Urol (2008) 0.75
Carcinoma in situ as a prognostic factor for G3pT1 bladder tumours. Br J Urol (1991) 0.75
Value of radical cystectomy in bladder cancer with pelvic node involvement. Eur Urol (1988) 0.75
[Isolated hematurias: histologic and immunologic study]. Nephrologie (1983) 0.75
[Urinary stress incontinence in women under 40 years of age]. Arch Esp Urol (1997) 0.75
[Ileovesical fistula in Crohn's disease]. Arch Esp Urol (2000) 0.75
[Cytogenetic characteristics and of primary culture in multiple renal tumors]. Actas Urol Esp (1993) 0.75
[Preventive chemotherapy of superficial tumors of the bladder]. J Urol (Paris) (1986) 0.75